Volume 42 Number 3 September 2024

REVIEW ARTICLE

Mpox and Vaccination

Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines; PART I: Insights into the virus and immune responses
Eakachai Prompetchara, Chutitorn Ketloy, Chirayus Khawsang, Kiat Ruxrungtham, Tanapat Palaga

Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines; PART II: Insights into the advancements in vaccines
Eakachai Prompetchara, Chutitorn Ketloy, Chirayus Khawsang, Tanapat Palaga, Kiat Ruxrungtham

Asthma

Association and correlation of patient symptom perception and asthma control – a rapid literature review
Hugo Neffen, Arzu Yorgancıoğlu, Hamdan Al-Jahdali, Steve McLachlan, Julie Myers, Christopher Bly, Pamela Martin, Saeed Noibi

Hereditary Angioedema

Long-term outcome of C1-esterase inhibitor deficiency
Luong Hoang Long, Tatsuya Fujioka, Timothy J Craig, Hirofumi Hitomi

ORIGINAL ARTICLE

Allergy Immunotherapy

A large scale multicentre randomized, placebo-controlled subcutaneous house dust mite allergen immunotherapy (HDM SCIT) in allergic rhinitis: MITAR Study
Narissara Suratannon, Ticha Limsuwan, Pongsakorn Tantilipikorn, Pantipa Chatchatee, Atik Saengapaswiriya, Tadech Boonpiyathad, Torpong Thongngarm, Boonsam Roongpuvapaht, Hiroshi Chantaphakul, Prapasri Kulalert, Sanguansak Thanaviratananich, Pasuree Sangsupawanich, Supranee Fooanant, Wiparat Manuyakorn, Supinda Chusakul, Orathai Piboonpochanun, Tanakorn Apornpong, Jongkonnee Wongpiyabovorn, Kiat Ruxrungtham, and MITAR Study Group

Atopic Dermatitis and Immunotherapy

A web-based survey on the behavior of moisturizer used in adults with and without atopic dermatitis in Thailand
Papapit Tuchinda, Leena Chularojanamontri, Chuda Rujitharanawong, Oraya Pochanapan, Kanokvalai Kulthanan

Successful treatment of atopic dermatitis with house dust mite sublingual immunotherapy tablets
Ploykarn Kiatiwat, Wat Mitthamsiri, Tadech Boonpiyathad, Panitan Pradubpongsa, Atik Sangasapaviliya

Food Allergy

Twelve-month growth and accession of tolerance in infants with cow’s milk protein allergy compared among those fed with breast milk or alternative formulae
Chonlada Trakulpark, Narumon Densupsoontorn

COVID-19 and Vaccination

A sero-epidemiological study after two waves of the COVID-19 epidemic
Raheema Abdul-Raheem, Sheena Moosa, Fazeela Waheed, Maimoona Aboobakuru, Ibrahim N Ahmed, Fathmath N. Rafeeg, Mariya Saeed

The immunogenicity and reactogenicity of four COVID-19 booster vaccinations against SARS-CoV-2 variants following CoronaVac or ChAdOx1 nCoV-19 primary series
Nasikarn Angkasekwinai, Suvimol Niyomnaitham, Jaturong Sewatanon, Supaporn Phumiamorn, Kasama Sukapirom, Sansnee Senawong, Zheng Quan Toh, Pinklow Umrod, Thitiporn Somporn, Supaporn Chumpol, Kanokphon Ritthitham, Yuparat Jantraphakorn, Kanjana Srisutthisamphan, Kulkanya Chokephaibulkit

Allergic Bronchopulmonary Mycosis

A case report of allergic bronchopulmonary mycosis caused by Alternaria alternata in colonization of Aspergillus
Min Ju Jo, Yoomi Yeo, Kyueng-Whan Min, Sung Jun Chung, Tai Sun Park, Hyun Lee, Dong Won Park, Ji-Yong Moon, Jang Won Sohn, Sang-Heon Kim, Ho Joo Yoon, Tae-Hyung Kim

Still’s Disease and Influenza Vaccine

Adult-onset Still’s disease preceded by influenza vaccination: Coincidence or true association?
Kanon Jatuworapruk

Calcineurin Inhibitors Resistance

CD28 confers CD4+ T cells with resistance to cyclosporin A and tacrolimus but to different degrees
Hiroyuki Kawai, Fumiko Yagyu, Aki Terada, Tsukasa Matsunaga, Manabu Inobe

ISSN: 2228-8694

Why should you submit to APJAI

APJAI is a peer-reviewed journal published quarterly by The Association of Allergy, Asthma and Immunology of Thailand (AAIAT) since 1983, the oldest of its kind in the Asia and Pacific regions. APJAI publishes a broad range and novel findings in the areas of allergy, immunology and related fields, including virology, microbiology and cancer both preclinical and clinical studies. APJAI is an open access journal with a rapid reviewing process. The 2021 release of the Impact Factor by Journal Citation Reports ® Science Edition is 7.143. APJAI is current ranked in Q1 of Allergy by JCR and Q1 of Medicine by SJR.

  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108